Monday, April 20, 2015 1:01:15 AM
Posted: Monday, April 20, 2015 12:00 am | Updated: 12:03 am, Mon Apr 20, 2015 I Compiled from www.drugs.com
Click For Link
Addiction starts with abuse. In 2011, 52 million people in the US over the age of 12 used prescription drugs non-medically at least once in their lifetime, 6.2 million in the past month. Abuse of prescription narcotic painkillers sit at the heart of the epidemic.
» The abuse of prescription drugs has risen to unprecedented levels. In fact, the number of people undergoing treatment for prescription painkiller drug abuse and addiction quadrupled from 2004 to 2010. In March 2014, the U.S. Attorney General stated that the growing number of deaths from prescription painkiller overdoses is an ‘urgent and growing public health crisis’.
» In 2012, young adults aged 18 to 25 used prescription drugs nonmedically at a rate of 5.3 percent — similar to rates in 2010-2011 rates, and lower than the 6.4 percent rate in 2009, according to SAMHSA. But opiate painkillers are not the only prescription drug subject to abuse and addiction.
» According to the National Institute of Health 2013 Monitoring the Future Survey, just over 28 percent of 12th graders in the survey had abused prescription medications in the previous 12 months. Six of the 11 drugs that were surveyed were prescription drugs. The top prescription drugs abused by teens included the ADHD stimulant Adderall (amphetamine mixed salts), Vicodin (acetaminophen/hydrocodone), and cold medicines. Unfortunately, ADHD medications and painkillers like hydrocodone are often easily accessible from the home medicine cabinet.
» Addiction is a chronic brain disease that causes compulsive drug seeking and use, despite harmful effects to the individual and others. Drug dependence is a complex disease process and the drug abuser cannot voluntarily stop their use of illicit or prescription drugs. People who become addicted to drugs are not necessarily immoral or lacking in character; in fact, drug addiction occurs throughout the mainstream of society. Brain circuit changes may challenge an addicted person’s self-control and hamper his or her ability to resist intense impulses to take drugs.
» Any opioid-based painkiller can lead to addiction. Opioid derivatives — or narcotics — are commonly used in prescription painkillers. Morphine, oxymorphone (Opana ER), oxycodone (Oxycontin, Oxecta), hydrocodone (Zohydro ER), codeine, methadone, and fentanyl are examples of the potent opiate medications at the center of the U.S. addiction epidemic. Also concerning is that many of these medications (such as Lorcet, Tylenol with Codeine #3, Vicodin) may also contain acetaminophen, which in itself can be toxic to the liver at excessive doses.
» All opioids (narcotics) will produce various levels of central nervous system depression and side effects such as drowsiness and sedation. In an overdose, you might notice stupor, coma, slurred speech, clammy skin, pinpoint pupils, and low blood pressure. The most dangerous side effect of an opioid overdose is slowed or arrested breathing. This risk is multiplied when the narcotic is combined with alcohol or other CNS depressants. If you believe someone has overdosed on narcotics, call 911 immediately.
» Benzodiazepines such as diazepam (Valium), alprazolam (Xanax), triazolam (Halcion), or lorazepam (Ativan) are a drug class at high risk for abuse and addiction. These drugs are prescribed medically to lower anxiety or for sleep. Clues of abuse include a slurred speech, poor concentration, lowered inhibitions, and impaired coordination. Like opiates, slowed breathing are risks with benzodiazepines, especially when combined with alcohol and other CNS depressants.
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
Recent TTNP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM